Notch signalling in solid tumours: A little bit of everything but not all the time

Nature Reviews Cancer

Volumn 11, Issue 5, 2011, Pages 338-351

  Ranganathan, Prathibha ^a   Weaver, Kelly L ^a   Capobianco, Anthony J ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; NOTCH RECEPTOR; OXALIPLATIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RAPAMYCIN; WORTMANNIN;

ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE REGULATION; COLORECTAL CANCER; DROSOPHILA MELANOGASTER; DRUG MECHANISM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SOLID TUMOR;

ANIMALS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 79955460636     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3035     Document Type: Review

References (170)

1. Ellisen, L.W. et al. TAN 1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66, 649-661 (1991). (Pubitemid 121001701)
2. Weng, A.P. et al. Activating mutations of NOTCH1 in human Tcell acute lymphoblastic leukemia. Science 306, 269-271 (2004). (Pubitemid 39336870)
3. Malecki, M.J. et al. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol. Cell. Biol. 26, 4642-4651 (2006). (Pubitemid 43877581)
4. Koch, U. & Radtke, F. Notch and cancer: a double-edged sword. Cell. Mol. Life Sci. 64, 2746-2762 (2007). (Pubitemid 351152259)
5. Hanlon, L. et al. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Res. 70, 4280-4286 (2010).
6. Plentz, R. et al. Inhibition of γsecretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology 136, 1741-1749 e1746 (2009).
7. Santagata, S. et al. JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res. 64, 6854-6857 (2004). (Pubitemid 39330990)
8. Miyamoto, Y. et al. Notch mediates TGF αinduced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3, 565-576 (2003). (Pubitemid 36808651)
9. Brennan, C. et al. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS ONE 4, e7752 (2009).
10. Reedijk, M. et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 65, 8530-8537 (2005). (Pubitemid 41330622)
11. Aster, J.C., Pear, W.S. & Blacklow, S.C. Notch signaling in leukemia. Annu. Rev. Pathol. 3, 587-613 (2008). (Pubitemid 351488294)
12. Gordon, W.R., Arnett, K.L. & Blacklow, S.C. The molecular logic of Notch signaling-a structural and biochemical perspective. J.Cell Sci. 121, 3109-3119 (2008).
13. Bray, S.J. Notch signalling: a simple pathway becomes complex. Nature Rev. Mol. Cell Biol. 7, 678-689 (2006). (Pubitemid 44268213)
14. Kopan, R. & Ilagan, M.X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216-233 (2009).
15. Kovall, R.A. More complicated than it looks: assembly of Notch pathway transcription complexes. Oncogene 27, 5099-5109 (2008).
16. Fortini, M.E. Notch signaling: the core pathway and its posttranslational regulation. Dev. Cell 16, 633-647 (2009).
17. LaVoie, M.J. & Selkoe, D.J. The Notch ligands, Jagged and Delta, are sequentially processed by αsecretase and presenilin/γsecretase and release signaling fragments. J.Biol. Chem. 278, 34427-34437 (2003). (Pubitemid 37553289)
18. Six, E. et al. The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and γsecretase. Proc. Natl Acad. Sci. USA 100, 7638-7643 (2003). (Pubitemid 36760022)
19. Bland, C.E., Kimberly, P. & Rand, M.D. Notch-induced proteolysis and nuclear localization of the Delta ligand. J.Biol. Chem. 278, 13607-13610 (2003). (Pubitemid 36799892)
20. Klueg, K.M., Parody, T.R. & Muskavitch, M.A. Complex proteolytic processing acts on Delta, a transmembrane ligand for Notch, during Drosophila development. Mol. Biol. Cell 9, 1709-1723 (1998). (Pubitemid 28337518)
21. D'Souza, B., Meloty-Kapella, L. & Weinmaster, G. Canonical and non-canonical Notch ligands. Curr. Top. Dev. Biol. 92, 73-129 (2010).
22. Ascano, J.M., Beverly, L.J. & Capobianco, A.J. The Cterminal PDZ-ligand of JAGGED1 is essential for cellular transformation. J.Biol. Chem. 278, 8771-8779 (2003). (Pubitemid 36800634)
23. Kolev, V. et al. The intracellular domain of Notch ligand Delta1 induces cell growth arrest. FEBS Lett. 579, 5798-5802 (2005). (Pubitemid 41455666)
24. Gallahan, D., Kozak, C. & Callahan, R. A new common integration region (int?3) for mouse mammary tumor virus on mouse chromosome 17. J.Virol. 61, 218-220 (1987). (Pubitemid 17212466)
25. Gallahan, D. & Callahan, R. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene 14, 1883-1890 (1997). (Pubitemid 27217801)
26. Gallahan, D. et al. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res. 56, 1775-1785 (1996). (Pubitemid 26118213)
27. Capobianco, A.J., Zagouras, P., Blaumueller, C.M., Artavanis-Tsakonas, S. & Bishop, J.M. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. Mol. Cell. Biol. 17, 6265-6273 (1997). (Pubitemid 27451170)
28. Demarest, R.M., Ratti, F. & Capobianco, A.J. It's T-ALL about Notch. Oncogene 27, 5082-5091 (2008).
29. Ronchini, C. & Capobianco, A.J. Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Mol. Cell. Biol. 21, 5925-5934 (2001). (Pubitemid 32737809)
30. Ling, H., Sylvestre, J.R. & Jolicoeur, P. Notch1 induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors. Oncogene 29, 4543-4554 (2010).
31. Cohen, B. et al. Cyclin D1 is a direct target of JAG1 imediated Notch signaling in breast cancer. Breast Cancer Res. Treat. 123, 113-124 (2010).
32. Sicinska, E. et al. Requirement for cyclin D3 in lymphocyte development and Tcell leukemias. Cancer Cell 4, 451-461 (2003). (Pubitemid 38050042)
33. Sharma, V.M. et al. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c imyc. Mol. Cell. Biol. 26, 8022-8031 (2006). (Pubitemid 44631001)
34. Weng, A.P. et al. Cimyc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 20, 2096-2109 (2006). (Pubitemid 44157460)
35. Klinakis, A. et al. Myc is a Notch1 transcriptional target and a requisite for Notch1 induced mammary tumorigenesis in mice. Proc. Natl Acad. Sci. USA 103, 9262-9267 (2006). (Pubitemid 43902566)
36. Palomero, T. et al. NOTCH1 directly regulates c imYC and activates a feed?forward?loop transcriptional network promoting leukemic cell growth. Proc. Natl Acad. Sci. USA 103, 18261-18266 (2006). (Pubitemid 44871646)
37. Murata, J. et al. Notch Hes1 pathway contributes to the cochlear prosensory formation potentially through the transcriptional down-regulation of p27Kip1. J.Neurosci. Res. 87, 3521-3534 (2009).
38. Monahan, P., Rybak, S. & Raetzman, L.T. The notch target gene HES1 regulates cell cycle inhibitor expression in the developing pituitary. Endocrinology 150, 4386-4394 (2009).
39. Riccio, O. et al. Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2. EMBO Rep. 9, 377-383 (2008).
40. Dohda, T. et al. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. Exp. Cell Res. 313, 3141-3152 (2007). (Pubitemid 47161022)
41. Mittal, S., Subramanyam, D., Dey, D., Kumar, R. & Rangarajan, A. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Mol. Cancer 8, 128 (2009).
42. Xu, P. et al. The oncogenic roles of Notch1 in astrocytic gliomas invitro and invivo. J.Neurooncol. 97, 41-51 (2010).
43. Liu, W., Singh, S.R. & Hou, S.X. JAK-STAT is restrained by Notch to control cell proliferation of the Drosophila intestinal stem cells. J.Cell. Biochem. 109, 992-999 (2010).
44. Li, T. et al. Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of γ-secretase. J.Biol. Chem. 282, 32264-32273 (2007). (Pubitemid 350106457)
45. Lefort, K. et al. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKα kinases. Genes Dev. 21, 562-577 (2007). (Pubitemid 46409471)
46. Wang, C. et al. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2 imediated p53 degradation and up-regulating p53-dependent DR5 expression. J.Biol. Chem. 284, 16183-16190 (2009).
47. Wang, L. et al. Overexpressed active Notch1 induces cell growth arrest of HeLa cervical carcinoma cells. Int. J.Gynecol. Cancer 17, 1283-1292 (2007). (Pubitemid 350077350)
48. Talora, C. et al. Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways. Exp. Cell Res. 305, 343-354 (2005). (Pubitemid 40462545)
49. Dotto, G.P. Crosstalk of Notch with p53 and p63 in cancer growth control. Nature Rev. Cancer 9, 587-595 (2009).
50. Shou, J., Ross, S., Koeppen, H., de Sauvage, F.J. & Gao, W.Q. Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res. 61, 7291-7297 (2001). (Pubitemid 32951774)
51. Whelan, J.T., Kellogg, A., Shewchuk, B.M., Hewan-Lowe, K. & Bertrand, F.E. Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression. J.Cell. Biochem. 107, 992-1001 (2009).
52. Bin Hafeez, B. et al. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase?9 and urokinase plasminogen activator. Clin. Cancer Res. 15, 452-459 (2009).
53. Niimi, H., Pardali, K., Vanlandewijck, M., Heldin, C.H. & Moustakas, A. Notch signaling is necessary for epithelial growth arrest by TGF-β. J.Cell Biol. 176, 695-707 (2007). (Pubitemid 46333983)
54. Sun, Y. et al. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-β signaling. Oncogene 24, 5365-5374 (2005). (Pubitemid 43080106)
55. Masuda, S. et al. Notch1 oncoprotein antagonizes TGF-β/Smad-mediated cell growth suppression via sequestration of coactivator p300. Cancer Sci. 96, 274-282 (2005). (Pubitemid 40895075)
56. Demehri, S., Turkoz, A. & Kopan, R. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 16, 55-66 (2009).
57. Dumortier, A. et al. Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin. PLoS ONE 5, e9258 (2010).
58. Demehri, S. et al. Notch-deficient skin induces a lethal systemic B?lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity. PLoS Biol. 6, e123 (2008).
59. Palomero, T., Dominguez, M. & Ferrando, A.A. The role of the PTEN/AKT Pathway in NOTCH1 induced leukemia. Cell Cycle 7, 965-970 (2008). (Pubitemid 351679827)
60. Nair, P., Somasundaram, K. & Krishna, S. Activated Notch1 inhibits p53 induced apoptosis and sustains transformation by human papillomavirus type16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway. J.Virol. 77, 7106-7112 (2003). (Pubitemid 36666904)
61. Meurette, O. et al. Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. Cancer Res. 69, 5015-5022 (2009).
62. Wendorff, A.A. et al. Hes1 is a critical but context-dependent mediator of canonical Notch signaling in lymphocyte development and transformation. Immunity 33, 671-684 (2010).
63. Mungamuri, S., Yang, X., Thor, A. & Somasundaram, K. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Res. 66, 4715-4724 (2006).
64. Beverly, L., Felsher, D. & Capobianco, A. Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression. Cancer Res. 65, 7159-7168 (2005). (Pubitemid 41161246)
65. Song, L.L. et al. Notch-1 associates with IKKα and regulates IKK activity in cervical cancer cells. Oncogene 27, 5833-5844 (2008).
66. Ramdass, B. et al. Coexpression of Notch1 and NF-κB signaling pathway components in human cervical cancer progression. Gynecol. Oncol. 104, 352-361 (2007). (Pubitemid 46135657)
67. Osipo, C., Golde, T.E., Osborne, B.A. & Miele, L.A. Off the beaten pathway: the complex cross talk between Notch and NF-κB. Lab. Invest. 88, 11-17 (2008).
68. Nakamura, T., Tsuchiya, K. & Watanabe, M. Crosstalk between Wnt and Notch signaling in intestinal epithelial cell fate decision. J.Gastroenterol. 42, 705-710 (2007). (Pubitemid 47456757)
69. Bienz, M. & Clevers, H. Linking colorectal cancer to Wnt signaling. Cell 103, 311-320 (2000).
70. Inomata, M., Ochiai, A., Akimoto, S., Kitano, S. & Hirohashi, S. Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res. 56, 2213-2217 (1996). (Pubitemid 26119927)
71. Satoh, S. et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nature Genet. 24, 245-250 (2000). (Pubitemid 30132191)
72. Korinek, V. et al. Constitutive transcriptional activation by a βcatenintcf complex in APC?/- colon carcinoma. Science 275, 1784-1787 (1997). (Pubitemid 27136714)
73. Caldwell, G. et al. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res. 64, 883-888 (2004). (Pubitemid 38176888)
74. Suzuki, H. et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nature Genet. 36, 417-422 (2004). (Pubitemid 38437267)
75. Katoh, M., Kirikoshi, H., Terasaki, H. & Shiokawa, K. WNT2B2 mRNA, up-regulated in primary gastric cancer, is a positive regulator of the WNT- βcatenintCF signaling pathway. Biochem. Biophys. Res. Commun. 289, 1093-1098 (2001). (Pubitemid 34076303)
76. Kirikoshi, H., Sekihara, H. & Katoh, M. Expression of WNT14 and WNT14B mRNAs in human cancer, up-regulation of WNT14 by IFNγ and up-regulation of WNT14B by β-estradiol. Int. J.Oncol. 19, 1221-1225 (2001).
77. Okino, K. et al. Up-regulation and overproduction of DVL-1, the human counterpart of the Drosophila dishevelled gene, in cervical squamous cell carcinoma. Oncol. Rep. 10, 1219-1223 (2003).
78. Terasaki, H., Saitoh, T., Shiokawa, K. & Katoh, M. Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT - β-catenin TCF signaling pathway. Int. J.Mol. Med. 9, 107-112 (2002).
79. Bjorklund, P., Akerstrom, G. & Westin, G. An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/β-catenin signaling. PLoS Med. 4, e328 (2007).
80. van Es, J. et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435, 959-963 (2005). (Pubitemid 40896322)
81. Axelrod, J., Matsuno, K., Artavanis-Tsakonas, S. & Perrimon, N. Interaction between Wingless and Notch signaling pathways mediated by dishevelled. Science 271, 1826-1832 (1996).
82. Couso, J. & Martinez Arias, A. Notch is required for wingless signaling in the epidermis of Drosophila. Cell 79, 259-272 (1994). (Pubitemid 24324916)
83. Giraldez, A. & Cohen, S. Wingless and Notch signaling provide cell survival cues and control cell proliferation during wing development. Development 130, 6533-6543 (2003). (Pubitemid 38088853)
84. Jin, Y. et al. β-catenin modulates the level and transcriptional activity of Notch1/NICD through its direct interaction. Biochim. Biophys. Acta 1793, 290-299 (2009).
85. Alves-Guerra, M., Ronchini, C. & Capobianco, A. Mastermind-like 1 is a specific coactivator of β-catenin transcription activation and is essential for colon carcinoma cell survival. Cancer Res. 67, 8690-8698 (2007). (Pubitemid 47437444)
86. Nicolas, M. et al. Notch1 functions as a tumor suppressor in mouse skin. Nature Genet. 33, 416-421 (2003). (Pubitemid 36278861)
87. Devgan, V., Mammucari, C., Millar, S.E., Brisken, C. & Dotto, G.P. p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev. 19, 1485-1495 (2005). (Pubitemid 41003015)
88. De La, O.J. et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc. Natl Acad. Sci. USA 105, 18907-18912 (2008).
89. De La, O.J. & Murtaugh, L.C. Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling. Cell Cycle 8, 1860-1864 (2009).
90. Weijzen, S. et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nature Med. 8, 979-986 (2002). (Pubitemid 35033702)
91. Claxton, S. & Fruttiger, M. Periodic Delta-like 4 expression in developing retinal arteries. Gene Expr. Patterns 5, 123-127 (2004). (Pubitemid 39529808)
92. Hellstrom, M. et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776-780 (2007). (Pubitemid 46279716)
93. Suchting, S. et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl Acad. Sci. USA 104, 3225-3230 (2007). (Pubitemid 46364141)
94. Mailhos, C. et al. Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 69, 135-144 (2001). (Pubitemid 33755062)
95. Patel, N. et al. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer. Clin. Cancer Res. 12, 4836-4844 (2006). (Pubitemid 44338568)
96. Thurston, G., Noguera-Troise, I. & Yancopoulos, G. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nature Rev. Cancer 7, 327-331 (2007). (Pubitemid 46652486)
97. Patel, N. et al. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res. 65, 8690-8697 (2005). (Pubitemid 41377356)
98. Noguera-Troise, I. et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444, 1032-1037 (2006). (Pubitemid 46018516)
99. Benedito, R. et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137, 1124-1135 (2009).
100. Panin, V.M., Papayannopoulos, V., Wilson, R. & Irvine, K.D. Fringe modulates Notch-ligand interactions. Nature 387, 908-912 (1997). (Pubitemid 27289592)
101. Fu, Y. et al. Differential regulation of transforming growth factor β signaling pathways by Notch in human endothelial cells. J.Biol. Chem. 284, 19452-19462 (2009).
102. Itoh, F. et al. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J. 23, 541-551 (2004). (Pubitemid 38282386)
103. Thiery, J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15, 740-746 (2003). (Pubitemid 37487967)
104. Leong, K. et al. Jagged1 imediated Notch activation induces epithelialto imesenchymal transition through Slug-induced repression of E-cadherin. J.Exp. Med. 204, 2935-2948 (2007). (Pubitemid 350179562)
105. Chen, J., Imanaka, N. & Griffin, J.D. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br. J.Cancer 102, 351-360 (2010).
106. Sahlgren, C., Gustafsson, M.V., Jin, S., Poellinger, L. & Lendahl, U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl Acad. Sci. USA 105, 6392-6397 (2008). (Pubitemid 351758356)
107. Zavadil, J., Cermak, L., Soto-Nieves, N. & Bottinger, E.P. Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelialto imesenchymal transition. EMBO J. 23, 1155-1165 (2004). (Pubitemid 38436879)
108. Mani, S. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008). (Pubitemid 351636299)
109. Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648 (1994). (Pubitemid 24067706)
110. Bonnet, D. & Dick, J. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 3, 730-737 (1997). (Pubitemid 27298715)
111. Cicalese, A. et al. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138, 1083-1095 (2009).
112. Al-Hajj, M., Wicha, M., Benito-Hernandez, A., Morrison, S. & Clarke, M. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983-3988 (2003). (Pubitemid 36418143)
113. Boiko, A.D. et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466, 133-137 (2010).
114. Lee, C., Dosch, J. & Simeone, D. Pancreatic cancer stem cells. J.Clin. Oncol. 26, 2806-2812 (2008).
115. Maitland, N. & Collins, A. Prostate cancer stem cells: a new target for therapy. J.Clin. Oncol. 26, 2862-2870 (2008).
116. O'Brien, C., Pollett, A., Gallinger, S. & Dick, J. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (2007). (Pubitemid 46067310)
117. Peacock, C. & Watkins, D. Cancer stem cells and the ontogeny of lung cancer. J.Clin. Oncol. 26, 2883-2889 (2008).
118. Prince, M. & Ailles, L. Cancer stem cells in head and neck squamous cell cancer. J.Clin. Oncol. 26, 2871-2875 (2008).
119. Sell, S. & Leffert, H. Liver cancer stem cells. J.Clin. Oncol. 26, 2800-2805 (2008).
120. Singh, S. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828 (2003). (Pubitemid 37187480)
121. Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760 (2006). (Pubitemid 44949604)
122. Dean, M., Fojo, T. & Bates, S. Tumour stem cells and drug resistance. Nature Rev. Cancer 5, 275-284 (2005). (Pubitemid 40488633)
123. Bao, S. et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 66, 7843-7848 (2006). (Pubitemid 44299144)
124. Pistollato, F. et al. Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate. Stem Cells 28, 1918-1929 (2010).
125. Varnum-Finney, B. et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nature Med. 6, 1278-1281 (2000).
126. Dontu, G. et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 6, R605-R615 (2004).
127. Farnie, G. & Clarke, R. Mammary stem cells and breast cancer-role of Notch signalling. Stem Cell Rev. 3, 169-175 (2007). (Pubitemid 350129719)
128. Farnie, G. et al. Novel cell culture technique for primary ductal carcinoma insitu: role of Notch and epidermal growth factor receptor signaling pathways. J.Natl Cancer Inst. 99, 616-627 (2007). (Pubitemid 47073543)
129. Zhang, X. et al. Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol. Cell. Biochem. 307, 101-108 (2008). (Pubitemid 350238652)
130. Hitoshi, S. et al. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev. 16, 846-858 (2002). (Pubitemid 34280108)
131. Hitoshi, S. et al. Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of Notch signaling. Genes Dev. 18, 1806-1811 (2004). (Pubitemid 39025091)
132. Nakamura, Y. et al. The bHLH gene hes1 as a repressor of the neuronal commitment of CNS stem cells. J.Neurosci. 20, 283-293 (2000). (Pubitemid 30220516)
133. Fan, X. et al. Notch pathway blockade depletes CD133?positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28, 5-16 (2009).
134. Meng, R.D. et al. γ-secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res. 69, 573-582 (2009).
135. Doucas, H. et al. Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt. J.Surg. Oncol. 97, 63-68 (2008).
136. Akiyoshi, T. et al. γ-secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. Gastroenterology 134, 131-144 (2008). (Pubitemid 350309314)
137. Ristorcelli, E., Beraud, E., Mathieu, S., Lombardo, D. & Verine, A. Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles. Int. J.Cancer 125, 1016-1026 (2009).
138. Wang, Z. et al. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-κB signaling pathways. J.Cell. Biochem. 109, 726-736 (2010).
139. Osipo, C. et al. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor. Oncogene 27, 5019-5032 (2008).
140. Hao, L. et al. Notch-1 activates estrogen receptor-αdependent transcription via IKKα in breast cancer cells. Oncogene 29, 201-213 (2010).
141. Lee, C.W. et al. A functional Notch-survivin gene signature in basal breast cancer. Breast Cancer Res. 10, R97 (2008).
142. Lee, C.W., Raskett, C.M., Prudovsky, I. & Altieri, D.C. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res. 68, 5273-5281 (2008).
143. Wang, J. et al. Notch promotes radioresistance of glioma stem cells. Stem Cells 28, 17-28 (2010).
144. Gilbert, C.A., Daou, M.C., Moser, R.P. & Ross, A.H. γ-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence. Cancer Res. 70, 6870-6879 (2010).
145. Dikic, I. & Schmidt, M.H. Notch: implications of endogenous inhibitors for therapy. Bioessays 32, 481-487 (2010).
146. Wu, Y. et al. Therapeutic antibody targeting of individual Notch receptors. Nature 464, 1052-1057 (2010).
147. Yin, L., Velazquez, O.C. & Liu, Z.J. Notch signaling: emerging molecular targets for cancer therapy. Biochem. Pharmacol. 80, 690-701 (2010).
148. Harrison, H. et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res. 70, 709-718 (2010).
149. Mazur, P.K. et al. Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. Proc. Natl Acad. Sci. USA 107, 13438-13443 (2010).
150. Tonon, G. et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nature Genet. 33, 208-213 (2003). (Pubitemid 36177076)
151. Enlund, F. et al. Altered Notch signaling resulting from expression of a WAMTP1 imAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp. Cell Res. 292, 21-28 (2004). (Pubitemid 38058260)
152. Lennerz, J.K., Perry, A., Mills, J.C., Huettner, P.C. & Pfeifer, J.D. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1 imAML2 gene fusion. Am. J.Surg. Pathol. 33, 835-843 (2009).
153. Behboudi, A. et al. Clear cell hidradenoma of the skin-A third tumor type with a t(11;19)-associated TORC1 imAML2 gene fusion. Genes Chromosomes Cancer 43, 202-205 (2005). (Pubitemid 40570740)
154. Martinez, A.M. et al. Polyhomeotic has a tumor suppressor activity mediated by repression of Notch signaling. Nature Genet. 41, 1076-1082 (2009).
155. Ferres-Marco, D. et al. Epigenetic silencers and Notch collaborate to promote malignant tumours by Rb silencing. Nature 439, 430-436 (2006). (Pubitemid 43152828)
156. Moshkin, Y.M. et al. Histone chaperones ASF1 and NAP1 differentially modulate removal of active histone marks by LID-RPD3 complexes during NOTCH silencing. Mol. Cell 35, 782-793 (2009).
157. Goodfellow, H. et al. Gene-specific targeting of the histone chaperone Asf1 to mediate silencing. Dev. Cell 13, 593-600 (2007). (Pubitemid 47500809)
158. Takeuchi, T., Adachi, Y. & Ohtsuki, Y. Skeletrophin, a novel ubiquitin ligase to the intracellular region of Jagged?2, is aberrantly expressed in multiple myeloma. Am. J.Pathol. 166, 1817-1826 (2005). (Pubitemid 40734404)
159. Takeuchi, T., Adachi, Y., Sonobe, H., Furihata, M. & Ohtsuki, Y. A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion. Oncogene 25, 7059-7069 (2006). (Pubitemid 44722073)
160. Wu, G. et al. SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol. Cell. Biol. 21, 7403-7415 (2001). (Pubitemid 32953491)
161. Akhoondi, S. et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 67, 9006-9012 (2007). (Pubitemid 47535882)
162. Miyaki, M. et al. Somatic mutations of the CDC4 (FBXW7) gene in hereditary colorectal tumors. Oncology 76, 430-434 (2009).
163. Lan, K. et al. Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein. Proc. Natl Acad. Sci. USA 104, 16287-16292 (2007). (Pubitemid 350099398)
164. McGill, M.A. & McGlade, C.J. Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J.Biol. Chem. 278, 23196-23203 (2003). (Pubitemid 36830386)
165. Pece, S. et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J.Cell Biol. 167, 215-221 (2004). (Pubitemid 39435065)
166. Colaluca, I.N. et al. NUMB controls p53 tumour suppressor activity. Nature 451, 76-80 (2008).
167. Matsuno, K., Diederich, R.J., Go, M.J., Blaumueller, C.M. & Artavanis-Tsakonas, S. Deltex acts as a positive regulator of Notch signaling through interactions with the Notch ankyrin repeats. Development 121, 2633-2644 (1995).
168. Matsuno, K. et al. Human deltex is a conserved regulator of Notch signalling. Nature Genet. 19, 74-78 (1998). (Pubitemid 28242028)
169. Izon, D.J. et al. Deltex1 redirects lymphoid progenitors to the Bcell lineage by antagonizing Notch1. Immunity 16, 231-243 (2002). (Pubitemid 34211963)
170. Yamamoto, N. et al. Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. J.Biol. Chem. 276, 45031-45040 (2001).